CONTROLLED RELEASE OF INTERLEUKIN-2 FROM BIODEGRADABLE MICROSPHERES

被引:74
作者
HORA, MS [1 ]
RANA, RK [1 ]
NUNBERG, JH [1 ]
TICE, TR [1 ]
GILLEY, RM [1 ]
HUDSON, ME [1 ]
机构
[1] SO RES INST,BIRMINGHAM,AL 35205
来源
BIO-TECHNOLOGY | 1990年 / 8卷 / 08期
关键词
D O I
10.1038/nbt0890-755
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We have evaluated the use of biodegradable poly(DL-lactide-co-glycolide) microspheres for the controlled release of inter-leukin-2 (IL-2) and its modified forms: succinyl IL-2 (SIL-2) and polyethylene glycol-modified IL-2 (PEG IL-2). We show that a microsphere formulation can be prepared from PEG IL-2 using HSA as an excipient which, after an initial burst, releases 2-3% PEG IL-2 per day in a bioac-tive form continuously over a 20- to 30-day period. © 1990 Nature Publishing Group.
引用
收藏
页码:755 / 758
页数:4
相关论文
共 28 条
[1]   POLY(DL-LACTIDE-CO-GLYCOLIDE) NORETHISTERONE MICROCAPSULES - AN INJECTABLE BIODEGRADABLE CONTRACEPTIVE [J].
BECK, LR ;
POPE, VZ ;
FLOWERS, CE ;
COWSAR, DR ;
TICE, TR ;
LEWIS, DH ;
DUNN, RL ;
MOORE, AB ;
GILLEY, RM .
BIOLOGY OF REPRODUCTION, 1983, 28 (01) :186-195
[2]   POTENTIAL USES OF INTERLEUKIN-2 IN CANCER-THERAPY [J].
CHEEVER, MA ;
THOMPSON, JA ;
PEACE, DJ ;
GREENBERG, PD .
IMMUNOBIOLOGY, 1986, 172 (3-5) :365-382
[3]  
CHEEVER MA, 1985, J IMMUNOL, V134, P3895
[4]  
CUTRIGHT DE, 1976, ADAO25988
[5]  
DELOACH JR, 1988, BIOTECHNOL APPL BIOC, V10, P183
[6]  
DONOHUE JH, 1983, J IMMUNOL, V130, P2203
[7]  
ETTINGHAUSEN SE, 1986, CANCER RES, V46, P2784
[8]   THE INTERNATIONAL STANDARD FOR HUMAN INTERLEUKIN-2 - CALIBRATION BY INTERNATIONAL COLLABORATIVE STUDY [J].
GEARING, AJH ;
THORPE, R .
JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 114 (1-2) :3-9
[9]   BIODEGRADABLE POLYMERS FOR USE IN SURGERY - POLYGLYCOLIC-POLY(ACTIC ACID) HOMOPOLYMERS AND COPOLYMERS .1. [J].
GILDING, DK ;
REED, AM .
POLYMER, 1979, 20 (12) :1459-1464
[10]  
GILLIS S, 1978, J IMMUNOL, V120, P2027